Chemoinformaics analysis of 2,3-Dihydroxypropyl acetate
| Molecular Weight | 134.131 | nRot | 3 |
| Heavy Atom Molecular Weight | 124.051 | nRig | 1 |
| Exact Molecular Weight | 134.058 | nRing | 0 |
| Solubility: LogS | 0.653 | nHRing | 0 |
| Solubility: LogP | -0.896 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 18.2259 |
| nHD | 2 | BPOL | 12.6361 |
| QED | 0.481 |
| Synth | 2.631 |
| Natural Product Likeliness | 1.891 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.037 |
| HIA | 0.207 |
| CACO-2 | -4.972 |
| MDCK | 0.0045207 |
| BBB | 0.232 |
| PPB | 0.126227 |
| VDSS | 0.542 |
| FU | 0.878178 |
| CYP1A2-inh | 0.022 |
| CYP1A2-sub | 0.072 |
| CYP2c19-inh | 0.016 |
| CYP2c19-sub | 0.445 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.152 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.163 |
| CYP3a4-inh | 0.008 |
| CYP3a4-sub | 0.104 |
| CL | 3.403 |
| T12 | 0.885 |
| hERG | 0.032 |
| Ames | 0.306 |
| ROA | 0.015 |
| SkinSen | 0.101 |
| Carcinogencity | 0.05 |
| EI | 0.267 |
| Respiratory | 0.017 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.957031 |